To include your compound in the COVID-19 Resource Center, submit it here.

Novartis biosimilars news

Novartis’ Sandoz Inc. unit said it plans to launch five biosimilars worldwide by 2020. The planned launches include

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE